Libbs Farmacêutica, founded in 1958, is a privately held Brazilian pharmaceutical company headquartered in São Paulo. The company's mission is to produce innovative pharmaceutical solutions that inspire a community committed to health. Libbs offers a wide range of products including medications for cardiology, oncology, gynecology, and central nervous system disorders. The company focuses on both the Brazilian market and international expansion, aiming to improve healthcare outcomes through high-quality and accessible medicines.
Notable figures associated with Libbs include its founding family and key executives who have driven the company’s growth over the decades. The company has achieved significant milestones, such as being one of the first in Brazil to receive Good Manufacturing Practices (GMP) certification. Libbs has also invested heavily in research and development, contributing to advancements in biotechnology and personalized medicine. Its impact is evident in its extensive reach across over 1,100 municipalities in Brazil, improving the quality of life for countless individuals.
